According to the guidelines [1], the RET mutation risk category, reflecting the clinical aggressiveness of the corresponding MTC and its correlated age-dependent development, should be currently used to plan the optimal timing of prophylactic thyroidectomy. The gene discussed is RET; the disease is medullary thyroid gland carcinoma.